Chargement en cours...
Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein
Drug resistance is one of the main hurdles for the successful treatment of breast cancer. The synchronous targeting of apoptosis resistance and survival signal transduction pathways may be a promising approach to overcome drug resistance. In this study, we determined that evodiamine (EVO), a major c...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4022620/ https://ncbi.nlm.nih.gov/pubmed/24830744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0097512 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|